Ionis Pharmaceuticals Aktie
WKN DE: A2ACMZ / ISIN: US4622221004
27.07.2022 13:05:00
|
Ionis to hold second quarter 2022 financial results webcast
Webcast scheduled for Tuesday, August 9 at 11:30 a.m. Eastern Time
CARLSBAD, Calif., July 27, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, August 9th at 11:30 a.m. Eastern Time to discuss its second quarter financial results and report on pipeline and business progress.
The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-second-quarter-2022-financial-results-webcast-301593812.html
SOURCE Ionis Pharmaceuticals, Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ionis Pharmaceuticals Incmehr Nachrichten
Analysen zu Ionis Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Ionis Pharmaceuticals Inc | 27,91 | -4,55% |
|